Evidence map›Paper›PMID 33900505›Full record

ArticleAMB Express2021

Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cells.

Hassan Noorbazargan, Sobhan Amintehrani, Aghigh Dolatabadi, Ainaz Mashayekhi, Nazanin Khayam, Pooria Moulavi, Mohammad Naghizadeh, Amir Mirzaie, Fatmeh Mirzaei Rad, Mahsa Kavousi

Open access · goldAbstract read
In one paragraph

Article in AMB Express, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Hassan Noorbazargan *Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. h.noorbazargan@gmail.com.ORCID http://orcid.org/0000-0003-1889-0139
Sobhan Amintehrani *Department of Biology, East Tehran Branch, Islamic Azad University, Tehran, Iran.
Aghigh DolatabadiDepartment of Biology, Tehran North Branch, Islamic Azad University, Tehran, Iran.
Ainaz MashayekhiDepartment of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Nazanin KhayamDepartment of Biology, East Tehran Branch, Islamic Azad University, Tehran, Iran.
Pooria MoulaviDepartment of Biology, East Tehran Branch, Islamic Azad University, Tehran, Iran.
Mohammad NaghizadehDepartment of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.
Amir MirzaieDepartment of Biology, Parand Branch, Islamic Azad University, Parand, Iran.
Fatmeh Mirzaei RadDepartment of Biology, Parand Branch, Islamic Azad University, Parand, Iran.
Mahsa KavousiDepartment of Biology, East Tehran Branch, Islamic Azad University, Tehran, Iran. mkavoosi@iauet.ac.ir.
Islamic Azad University South Tehran Branch · IRIslamic Azad University of Parand · IRIslamic Azad University Central Tehran Branch · IRIslamic Azad University Medical Branch of Tehran · IRIslamic Azad University North Tehran Branch · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study evaluated the anti-cancer properties of bio-functionalized silver nanoparticles fabricated by Juniperus chinensis leaf extracts. The nanoparticles were characterized by scanning electron microscopy, transmission electron microscopy, UV-visible spectroscopy, Fourier transform infrared spectroscopy, X-ray diffraction, dynamic light scattering, Zeta potential and X-ray spectroscopy. Further, this study elucidated the cellular and molecular mechanisms of nanoparticles for anti-proliferative and apoptotic effects on human lung cancer cells (A549) and compared them with commercial drug cisplatin. The size of the spherical nanoparticle was 12.96 nm with negative zeta potential. Up-regulation of caspase 3,9 and p53, Annexin V-FITC/PI, DAPI staining, and ROS production indicated the remarkable apoptotic effect of AgNPs compared to cisplatin. Moreover, down-regulation of MMP2/MMP9 scratch and matrigel assays revealed anti-metastatic properties of AgNPs. Cell cycle analysis and downregulation of cyclin D1 indicated cancer cell cessation in the G0/G1 phase. Overall, the results revealed that the green-synthetized AgNPs had anti-metastasis and anti-proliferation effects on lung cancer cells in comparison to cisplatin with lower side effects on the normal cell line.

Indexed as

ApoptosisGreen synthesized AgNPsHuman lung cancer cellsJuniperus chinensisMetastasis

Identifiers

PMID33900505
PMCPMC8076435
OpenAlexW3159678203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.